A.J. Mbekeani
Mining for natural product antileishmanials in a fungal extract library
Mbekeani, A.J.; Jones, R.S.; Bassas Llorens, M.; Elliot, J.; Regnault, C.; Barrett, M.P.; Steele, J.; Kebede, B.; Wrigley, S.K.; Evans, L.; Denny, P.W.
Authors
R.S. Jones
M. Bassas Llorens
J. Elliot
C. Regnault
M.P. Barrett
J. Steele
B. Kebede
S.K. Wrigley
L. Evans
Professor Paul Denny p.w.denny@durham.ac.uk
Professor
Abstract
Leishmaniasis is a Neglected Tropical Disease caused by the insect-vector borne protozoan parasite, Leishmania species. Infection affects millions of the World's poorest, however vaccines are absent and drug therapy limited. Recently, public-private partnerships have developed to identify new modes of controlling leishmaniasis. Most of these collaborative efforts have relied upon the small molecule synthetic compound libraries held by industry, but the number of New Chemical Entities (NCE) identified and entering development as antileishmanials has been very low. In light of this, here we describe a public-private effort to identify natural products with activity against Leishmania mexicana, a causative agent of cutaneous leishmanaisis (CL). Utilising Hypha Discovery's fungal extract library which is rich in small molecule (<500 molecular weight) secondary metabolites, we undertook an iterative phenotypic screening and fractionation approach to identify potent and selective antileishmanial hits. This led to the identification of a novel oxidised bisabolane sequiterpene which demonstrated activity in an infected cell model and was shown to disrupt multiple processes using a metabolomic approach. In addition, and importantly, this study also sets a precedent for new approaches for CL drug discovery.
Citation
Mbekeani, A., Jones, R., Bassas Llorens, M., Elliot, J., Regnault, C., Barrett, M., …Denny, P. (2019). Mining for natural product antileishmanials in a fungal extract library. International Journal for Parasitology: Drugs and Drug Resistance, 11, 118-128. https://doi.org/10.1016/j.ijpddr.2019.05.003
Journal Article Type | Article |
---|---|
Acceptance Date | May 20, 2019 |
Online Publication Date | Jun 11, 2019 |
Publication Date | Dec 31, 2019 |
Deposit Date | Jun 11, 2019 |
Publicly Available Date | Dec 5, 2019 |
Journal | International Journal for Parasitology: Drugs and Drug Resistance |
Print ISSN | 2211-3207 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Pages | 118-128 |
DOI | https://doi.org/10.1016/j.ijpddr.2019.05.003 |
Public URL | https://durham-repository.worktribe.com/output/1299715 |
Files
Published Journal Article
(3 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
© 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
You might also like
Chalcones identify cTXNPx as a potential antileishmanial drug target
(2021)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search